• Howard Scher, a veteran of prostate-cancer studies and chief of the genitourinary oncology service at Memorial Sloan-Kettering Cancer, agreed to run the research, which began in 2007.

    WSJ: New Medical Strides Against Prostate Cancer

  • For Schering, which has been making strides into biotech and cancer treatment with a treatment for multiple sclerosis and Campath, a cancer drug licensed from Ilex Oncology (nasdaq: ILXO - news - people ), it is a strategic step forward.

    FORBES: Schering AG Makes Biotech Strides

  • Anna Git, Cancer Research UK Cambridge Research Institute, Oncology Dr Anna Git will use her For Women In Science Fellowship to support her research at the Cancer Research UK Cambridge Research Institute.

    UNESCO: 2007 UK and Ireland Fellows

  • "These are among the most significant findings in drugs for metastatic cancer in the past five years, " said Eric Winer, director of the breast oncology center at Dana-Farber Cancer Institute in Boston, who wasn't directly involved in the trials.

    WSJ: Breast-Cancer Drugs Raise Hopes

  • The American Society of Clinical Oncology, which represents cancer specialists, including those treating prostate cancer patients, supports the Cancer Society guidelines.

    CNN: Let men decide on prostate screening, cancer society says

  • The research was discussed Tuesday in a telephone news conference sponsored by the American Society of Clinical Oncology and two other cancer groups.

    WSJ: Study questions kidney cancer treatment in elderly

  • The American Society of Clinical Oncology and the National Cancer Institute, both of which have guidelines for how to talk to children about cancer, stress the importance of honesty.

    CNN: 'Honey, you're really sick'

  • "To specifically overcome resistance to hormone treatment that's sort of a paradigm change, " said Gabriel Hortobagyi, head of breast oncology at MD Anderson Cancer Center in Houston and lead author of Bolero-2.

    WSJ: Breast-Cancer Drugs Raise Hopes

  • Charles Baum, who heads Pfizer's oncology development program, says cancer drugs now account for 20% of the money Pfizer is spending on drug testing.

    FORBES: Magazine Article

  • Friedman is a renowned expert in neurosurgery and neuro-oncology, the study of brain cancer.

    NPR: Doctors: Kennedy Brain Surgery a Success

  • " Says Robert Mayer , director of the center for gastrointestinal oncology at the Dana-Farber Cancer Institute: "I think it's hard to be anything but enthusiastic about the results.

    FORBES: Magazine Article

  • "Partial-breast irradiation is a very promising approach, but there's a lot we have to learn, " says Lori Pierce, professor of radiation oncology at University of Michigan Comprehensive Cancer Center.

    WSJ: New Scrutiny for Popular Breast-Cancer Treatment

  • In fact, says Robert Mayer Robert Mayer , director for the center of gastrointestinal oncology at the Dana-Farber Cancer Center, the statins are enticing but less promising than other drugs developed more specifically for cancer.

    FORBES: Can Cholesterol Drugs Prevent Cancer?

  • In fact, says Robert Mayer , director for the center of gastrointestinal oncology at the Dana-Farber Cancer Center, the statins are enticing but less promising than other drugs developed more specifically for cancer.

    FORBES: Can Cholesterol Drugs Prevent Cancer?

  • Right now, despite the influx of cancer drugs into human tests, the field of oncology is in a lull.

    FORBES: Cancer Revolution, Or Me-Too Mess?

  • The past two annual cancer meetings held by the American Society for Clinical Oncology have delivered few such surprises.

    FORBES: Cancer Revolution, Or Me-Too Mess?

  • Winer, director of the Breast Oncology Center at the Dana-Farber Cancer Institute.

    FORBES: Questions Swirl Around Avastin

  • Novartis is emerging as the surprise winner at this year's annual meeting of the American Society of Clinical Oncology, the year's biggest cancer conference.

    FORBES: Magazine Article

  • "That is absolutely the case, " agrees Dr. Ann Partridge, clinical director of the Breast Oncology Center at the Dana-Farber Cancer Institute, who also does research on improving health care communication.

    CNN: Cancer survivor's own fat gives her new breasts

  • Apart from its anti-cancer drugs Fusilev and Zevalin, Spectrum has 10 other oncology drug candidates that are now in clinical development, two of them in phase 3 clinical trials and several undergoing phase 1 and 2 clinical studies.

    FORBES: Why This Tiny But Profitable Biotech May Be Gobbled Up By Big Pharma

  • The cancer therapy may be just what Bristol needs to boost its oncology practice.

    FORBES: Bristol-Myers Zeros In On Drugs

  • Last year the Sidney Kimmel Cancer Center lured Dr. Albert Deisseroth, former head of oncology at Yale, to become its new president.

    FORBES: Regions

  • "Support groups can be very tricky and challenging, and leaders can't hesitate to facilitate, " says Sherry Martin, an oncology social worker at Centura Health's Penrose Cancer Center in Colorado Springs, Colo.

    WSJ: Giving More Support to Support-Group Leaders

  • "That led to the idea that one could give most or all of the radiation closer to the original tumor bed and that would solve the problem, " says George Sledge, a past president of the American Society of Clinical Oncology and co-director of the breast-cancer program at Indiana University Simon Cancer Center, in Indianapolis.

    WSJ: New Scrutiny for Popular Breast-Cancer Treatment

  • Dr. Mark Kieran, director of pediatric medical neuro-oncology at Boston Children's Hospital and Dana Farber Cancer Insititute, is the principal investigator of the study.

    CNN: Advances in kids' early aging disease

  • Last summer, Pfizer (nyse: PFE - news - people ) presented data at the annual meeting of the American Society of Clinical Oncology indicating that the drug may be effective in kidney cancer.

    FORBES: Pfizer Cancer Pill Proves Effective

  • Results in lowering the risk of breast cancer were presented at a press briefing at the American Society for Clinical Oncology.

    FORBES: Can Cholesterol Drugs Prevent Cancer?

  • "We hope that Pfizer will, in time, grow into one of the larger cancer companies, " says William Slichenmyer , Pfizer's head of oncology.

    FORBES

  • In May, it was one of the stars of the annual meeting of the American Society for Clinical Oncology. (See: "Pfizer Takes Cancer By Storm").

    FORBES: McKinnell's Pfizer Submits 'Revolutionary' Cancer Drug

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定